For each euro that the Vall d’Hebron Institute of Research (VHIR) spent in 2012, generated 2, according to a "http://www20.gencat.cat/docs/canalsalut/Minisite/ObservatoriSalut/ossc_Central_resultats/Informes/Fitxers_estatics/Recerca_salut_monografic_9.pdf" monographic study of the Chamber of Comerce and the "http://www20.gencat.cat/portal/site/canalsalut/menuitem.dbb85aa2c955c7c3ba963bb4b0c0e1a0/?vgnextoid=9cd1a82c8af25310VgnVCM1000008d0c1e0aRCRD&vgnextchannel=9cd1a82c8af25310VgnVCM1000008d0c1e0aRCRD&vgnextfmt=default" Central de Resultats about the two biggest research institutes of health in Catalonia. The Catalan government presented this study and "http://www20.gencat.cat/docs/canalsalut/Minisite/ObservatoriSalut/ossc_Central_resultats/Informes/Fitxers_estatics/Central_resultats_recerca_ciencies_salut_2013.pdf" another one that concludes that for each euro that they invested, the Institute raised 19.The monographic compared the results of the VHIR, excluding the Vall d’Hebron Institute of Oncology (VHIO), with the August Pi i Sunyer Biomedical Research Institute (IDIBAPS) and the Clinic Foundation for Biomedical Research, both associated to the Hospital Clínic in Barcelona. The study highlighted that both centers generated an economic impact equivalent to the double of their budget in 2012. Specifically, VHIR generated in the short term 68.1 million euros of economic activity, from the 32.2 millions of its budget. On the other side, the centers of the Hospital Clínic received from the Catalan government 5.6 million euros, whereas VHIR, 1.5 million euros. Nonetheless, both centers returned to the public administration the 80% and the 50% respectively of the funds obtained through public calls. Regarding the study of the 19 centers and institutes of biomedical research in Catalonia, the first conclusion is that for each euro that the Catalan government invested in 2012 in these centers, they managed to raise 3 additional euros. In the case of the VHIR is higher because from the 1.5 million euros that the Generalitat invested, they raised 28,5 million euros through competitive calls and other resources, which represents 19 euros raised for each euro granted by the Catalan government.The study also remarked the leadership of Vall d’Hebron in clinical trials: in 2012 there were in Catalonia 2,853 active clinical trials, from which one third where conducted at VHIR, with a great participation of the VHIO in the oncology treatments. Thanks to the resources obtained from the clinical trials and the agreements with the industry, VHIR obtained 18 million euros, which is much more than the rest of the Catalan research institutes of health. "premsa.gencat.cat/pres_fsvp/docs/2014/06/19/14/40/472f4ffd-2bd2-4a19-94bf-8afeb32e21f7.pdf" Read the summary of the studies on this link